Diseases, Conditions, Syndromes

New focus for chronic liver disease care

Developing improved care models for decompensated liver disease is one of the major clinical challenges in gastroenterology and hepatology, and in a recent landmark study, published in Hepatology, researches from Flinders ...

Medications

Plozasiran reduces triglyceride levels by 74% at 24 weeks

In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing ...

page 2 from 4